A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
University of Nebraska
University of Nebraska
National Cancer Institute (NCI)
National Cancer Institute (NCI)
NRG Oncology
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
Mayo Clinic
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Stanford University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Emory University
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Northwell Health
Lumos Pharma
University of Nebraska
Mayo Clinic
Canadian Cancer Trials Group
Canadian Cancer Trials Group
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
AbbVie
Center Trials & Treatment Europe
Case Comprehensive Cancer Center
Children's Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Duke University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Duke University
Jonsson Comprehensive Cancer Center
Eli Lilly and Company
Lumos Pharma
Massachusetts General Hospital
Northwestern University
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Virginia Commonwealth University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Abramson Cancer Center at Penn Medicine